[go: up one dir, main page]

WO2012017128A2 - Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci - Google Patents

Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci Download PDF

Info

Publication number
WO2012017128A2
WO2012017128A2 PCT/ES2011/070586 ES2011070586W WO2012017128A2 WO 2012017128 A2 WO2012017128 A2 WO 2012017128A2 ES 2011070586 W ES2011070586 W ES 2011070586W WO 2012017128 A2 WO2012017128 A2 WO 2012017128A2
Authority
WO
WIPO (PCT)
Prior art keywords
vitamin
rosemary extract
composition based
menopause
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/ES2011/070586
Other languages
English (en)
Spanish (es)
Other versions
WO2012017128A3 (fr
WO2012017128A1 (fr
Inventor
Enrique De Miguel Del Campo
Guillermo Reglero Rada
Carlota Largo Aramburu
Fornari Reale
Mónica RODRÍGUEZ GARCÍA-RISCO
Laura Jaime De Pablo
Susana Santoyo Diez
Francisco Javier SEÑORANS RODRÍGUEZ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Original Assignee
Universidad Autonoma de Madrid
Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Universidad Autonoma de Madrid, Fundacion para la Investigacion Biomedica del Hospital Universitario La Paz filed Critical Universidad Autonoma de Madrid
Publication of WO2012017128A2 publication Critical patent/WO2012017128A2/fr
Publication of WO2012017128A1 publication Critical patent/WO2012017128A1/fr
Publication of WO2012017128A3 publication Critical patent/WO2012017128A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/53Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105Plant extracts, their artificial duplicates or their derivatives
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/15Vitamins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/3533,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355Tocopherols, e.g. vitamin E
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Mycology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Botany (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne une composition comprenant un extrait de romarin et de la vitamine E, laquelle composition peut être utilisée comme complément alimentaire et pour préparer des compositions pharmaceutiques destinées à réduire les processus inflammatoires et la peroxydation lipidique de manière générale, en particulier les processus associés à la ménopause, et à prévenir et/ou traiter les effets secondaires des rayonnements ionisants.
PCT/ES2011/070586 2011-08-05 Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci Ceased WO2012017128A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
ESP201031225 2010-08-05
ES201031225A ES2374482B1 (es) 2010-08-05 2010-08-05 Composición para la reducción de síntomas asociados a la menopausia.

Publications (3)

Publication Number Publication Date
WO2012017128A2 true WO2012017128A2 (fr) 2012-02-09
WO2012017128A1 WO2012017128A1 (fr) 2012-02-09
WO2012017128A3 WO2012017128A3 (fr) 2012-03-08

Family

ID=

Also Published As

Publication number Publication date
ES2374482B1 (es) 2012-12-27
WO2012017128A3 (fr) 2012-03-08
ES2374482A1 (es) 2012-02-17

Similar Documents

Publication Publication Date Title
WO2008153945A3 (fr) Compositions nutraceutiques de co-cristal
Macáková et al. Tannins and their influence on health
WO2014188276A3 (fr) Compositions d'antioxydants et procédés d'utilisation
WO2016086206A8 (fr) Compositions probiotiques contenant des clostridiales pour inhiber une inflammation
WO2010000877A3 (fr) Formulation à base de bisabolol et de [6]-paradol produisant un effet apaisant sur les irritations
NZ611606A (en) Low eructation composition and methods for treating and/or preventing cardiovascular disease in a subject with fish allergy/hypersensitivity
WO2009050580A8 (fr) Composition destinee a la regulation du metabolism des lipides
WO2014179629A8 (fr) Compositions et procédés
HK1205942A1 (en) Compositions, methods, and kits for regulating energy metabolism
EA033311B1 (ru) Производные бензоксаборола в качестве антибактериальных средств
WO2014057362A3 (fr) Compositions d'oméga 3
HK1202415A1 (en) Pharmaceutical compositions comprising dgla, 15-ohepa, and/or 15-hetre and methods of use thereof
WO2013150386A3 (fr) Compositions comprenant des acides gras oméga-3 et de la vitamine d destinées à lutter contre l'acné vulgaire et/ou l'eczéma, et méthodes et utilisations associées
WO2012049222A3 (fr) Nouvelles compositions contenant des acides gras oméga-3 et oméga-6 et leurs utilisations
PH12017500641A1 (en) Nutritional compositions comprising an oxidizablecomponent and water-soluble plant extract
HK1222563A1 (zh) 药物组合物、制备及其用途
WO2015067336A3 (fr) Polymères conjugués
NZ716154A (en) Tricyclic benzoxaborole compound, preparation method therefor, and use thereof
WO2014043230A3 (fr) Formulations comprenant de l'idébénone, de la n-acétyl-s-farnésyl-l-cystéine et de l'ergothionéine et leurs utilisations
MX2012007587A (es) Composiciones nutricionales que comprenden hojuelas de frutas que incluyen acido docosahexaenoico.
WO2013100718A3 (fr) Composition pharmaceutique permettant de prévenir ou de traiter des maladies inflammatoires ou l'asthme, contenant un extrait de lagerstroemia ovalifolia ou une fraction de celle-ci en tant que principe actif
HK1199841A1 (en) Acamprosate formulations, methods of using the same, and combinations comprising the same
WO2012134172A3 (fr) Composition contenant, comme ingrédient actif, une fraction d'acétate d'éthyle de schisandra chinensis baill, ou wuweizisu c séparée de la fraction, pour prévenir ou traiter l'obésité
WO2013037985A8 (fr) Combinaisons pharmaceutiques contenant des conjugués anti-inflammatoire- antioxydant et destinées à être utilisées en vue du traitement d'affections métaboliques
WO2012017128A2 (fr) Composition à base d'extrait de romarin et de vitamine e et applications de celle-ci

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 11814154

Country of ref document: EP

Kind code of ref document: A2